← Back to headlines
Neurocrine Acquires Hunger-Drug Maker in Multi-Billion-Dollar Pharma Deal
Neurocrine Biosciences has acquired a hunger-drug maker in a multi-billion-dollar pharmaceutical deal, marking the latest significant transaction in the industry. This acquisition expands Neurocrine's pipeline and market presence in the therapeutic area of weight management.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippine Lawmaker Proposes VAT Cut Amid Fuel Crisis
just now
Ukraine's Fight to Prevent Financial Crisis: Military Levy to Be Paid Even After the War Ends
just now
JPMorgan says Anthropic's groundbreaking cybersecurity model positive for these two stocks
20m ago
Global economy shows more resilience to oil shocks - BofA
23m ago